SunTrust Upgrades Sarepta Therapeutic (SRPT) to Neutral
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $20.14 +0.15%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
SunTrust Robinson Humphrey upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Reduce to Neutral with a price target of $48.00 (from $4.00).
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $28.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy
- RBC Capital Starts Tabcorp Holdings (TAH:AU) (TABCF) at Outperform
- BofA Securities Starts Ather Energy Ltd (ATHERENE:IN) at Buy
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
